Keyphrases
Bone Morphogenetic protein-2 (BMP-2)
100%
Fibroblasts
100%
Teratoma
100%
Osteogenesis
100%
Fibroblast Cells
60%
Bone Formation
40%
Herpes Simplex Virus Thymidine Kinase
40%
High Efficiency
20%
MRNA Expression
20%
Therapeutic Use
20%
Potential Therapeutics
20%
Success Rate
20%
Bone Regeneration
20%
Alkaline Phosphatase Activity
20%
Induced Apoptosis
20%
Tumor Formation
20%
Growth Factors
20%
Encoding Gene
20%
Calvaria
20%
Critical Size Defect
20%
Stem Cell Therapy
20%
Marker Genes
20%
Calcium Content
20%
Osteoinductive
20%
Defect Model
20%
Clinical Investigation
20%
Teratoma Formation
20%
Osteogenic Markers
20%
Formation Volume
20%
In Vitro Osteogenesis
20%
Herpes Simplex Virus Thymidine Kinase Suicide Gene
20%
2-simplex
20%
Ganciclovir Treatment
20%
Self-production
20%
Medicine and Dentistry
Dentigerous Cyst
100%
Bone Morphogenetic Protein 2
100%
Bone Development
100%
Fibroblast
100%
Thymidine Kinase
60%
Herpes Simplex Virus
60%
Ossification
40%
Programmed Cell Death
20%
In Vitro
20%
Isotopes of Calcium
20%
Growth Factor
20%
Stem Cell Therapy
20%
Marker Gene
20%
Side Effect
20%
Carcinogenesis
20%
Bone Regeneration
20%
Alkaline Phosphatase
20%
Ganciclovir
20%
Messenger RNA
20%
Biochemistry, Genetics and Molecular Biology
Bone Morphogenetic Protein 2
100%
Teratoma
100%
Bone Development
100%
Fibroblast
100%
Thymidine Kinase
60%
Herpes Simplex Virus
60%
Ossification
40%
Carcinogenesis
20%
Growth Factor
20%
Stem Cell Transplantation
20%
Alkaline Phosphatase
20%
Marker Gene
20%
Bone Regeneration
20%
Messenger RNA
20%
Pharmacology, Toxicology and Pharmaceutical Science
Bone Morphogenetic Protein 2
100%
Teratoma
100%
Thymidine Kinase
60%
Herpes Simplex Virus
60%
Carcinogenesis
20%
Alkaline Phosphatase
20%
Calcium
20%
Side Effect
20%
Growth Factor
20%
Ganciclovir
20%
Messenger RNA
20%